跳至主要内容
临床试验/NCT05473832
NCT05473832已完成不适用

Evaluation of the Anti-aging Efficacy of Four Cosmetic Products

Amazentis SA1 个研究点 分布在 1 个国家目标入组 144 人开始时间: 2022年7月13日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
Amazentis SA
入组人数
144
试验地点
1
主要终点
Anti-wrinkle efficacy will be assessed in the periorbital regions wrinkles using DermaTOP. Parameters measured: Rz and Ra, representing mainly the rough structure (Rz) or the finer skin structure (Ra).

研究概览

简要总结

The purpose of this study is to assess the anti-wrinkle and anti-aging efficacy of four different cosmetic products compared to an untreated control (split-face study design)

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Basic Science
盲法
None

入排标准

年龄范围
40 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Written Informed Consent to participate in the study
  • Willingness to actively participate in the study and to come to the scheduled visits
  • Female and male
  • From 40 to 65 years of age
  • BMI < 30 kg/m2
  • Healthy skin in the test areas
  • Uniform skin color and no erythema or dark pigmentation in the test area
  • Visible wrinkle in the face (grade 3 to 6 according to proderm scale) see Appendix 2
  • Ethnicity: at least one Black, Asian and Hispanic subject per study group

排除标准

  • Female subjects: Pregnancy or lactation
  • Drug addicts, alcoholics
  • AIDS, HIV-positive or infectious hepatitis
  • Conditions which exclude a participation or might influence the test reaction/evaluation
  • Participation or being in the waiting period after participation in cosmetic and/or pharmaceutical studies pertaining to the test area
  • Active skin disease at the test area
  • Documented allergies to face/eye care products
  • Diabetes mellitus
  • Cancer not being diagnosed as cured and requiring chemotherapy, irradiation and/or hormonal treatment within the last 2 years One of the following illnesses with reduced physical capability/fitness: asthma (symptom-free allergic asthma is not an exclusion criterion), hypertension (if not adjusted with medication), cardiovascular diseases
  • Wounds, moles, tattoos, scars, irritated skin, excessive hair growth, freckles, etc. at the test area that could influence the investigation
  • Sun-tanned skin (important for the subgroup of subjects planned for Raman measurements)
  • Regular use of tanning beds
  • Any topical medication at the test area within the last 7 days prior to the start of the study
  • Systemic therapy with immuno-suppressive drugs (e.g. corticosteroids) and/or antihistamines (e.g. antiallergics) and/or within the last 7 days prior to the start of the study
  • Past cosmetic surgery procedure in the test area (e.g. laser, facelift)
  • Cosmetic surgery procedure in the test area, e.g. IPL (Intensed Pulsed Light), botox, chemical peel, dermabrasion within the last 2 years prior to the start of the study and/or throughout the entire course of the study
  • Medical treatment for wrinkle reduction (e.g. peeling with vitamin A or fruit acids) on the face within the last 2 weeks prior to the start of the study

结局指标

主要结局

Anti-wrinkle efficacy will be assessed in the periorbital regions wrinkles using DermaTOP. Parameters measured: Rz and Ra, representing mainly the rough structure (Rz) or the finer skin structure (Ra).

时间窗: 8-weeks

次要结局

  • Change from baseline in skin elasticity by Cutometer after 2, 4 and 8 weeks(8-weeks)
  • Change from baseline in ceramides by Raman Spectroscopy [a.u.] on a subgroup of n=12 subjects per test product group after 2, 4 and 8 weeks(8-weeks)
  • Change in Image grading (Photodocumentation via USR-Clip) for skin radiance (3 trained graders will rank each pair of images in a blinded fashion) after 2, 4 and 8 weeks(8-weeks)
  • Change from baseline in skin firmness by Cutometer [mm] after 2, 4 and 8 weeks(8-weeks)
  • Change in wrinkle scores (Photodocumentation via USR-Clip) for anti-wrinkle efficacy (3 trained graders will rank each pair of images at the area of the crow feet's in a blinded manner)(8-weeks)
  • Change from baseline in skin hydration (assessed on skin capacitance by Corneometer [a.u.]) after 2, 4 and 8 weeks(8-weeks)
  • Change from baseline in skin barrier function (assessed on transepidermal waterloss by Tewameter [g/(m²h)]) after 2, 4, 8-weeks(8-weeks)
  • Subjective Evaluation of product traits assessed via questionnaire after 2, 4 and 8 weeks(8-weeks)

研究者

发起方
Amazentis SA
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验